FFCP PHASE1:Mm9::chr5:137453946..137453948,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=6|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr5:137453946..137453948,+|id=chr5:137453946..137453948,+|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=CL:0000355,1.75e-07,9|ontology_enrichment_disease=DOID:0060100!2.69e-14!3;DOID:4045!2.69e-14!3;DOID:0050686!2.26e-07!6|ontology_enrichment_disease_v019_2=DOID:0060100,1.99e-20,3;DOID:4045,1.99e-20,3;DOID:0050686,9.54e-11,6|ontology_enrichment_uberon=|ontology_enrichment_uberon_v019_2=UBERON:0001134,1.75e-07,9;UBERON:0002036,1.75e-07,9;UBERON:0002385,1.75e-07,9;UBERON:0000486,1.75e-07,9;UBERON:0007503,1.75e-07,9;UBERON:0001015,1.75e-07,9;UBERON:0002329,1.75e-07,9;UBERON:0003082,1.75e-07,9;UBERON:0003059,1.75e-07,9;UBERON:0007282,1.75e-07,9;UBERON:0004290,1.75e-07,9;UBERON:0009618,1.75e-07,9;UBERON:0000383,7.98e-07,10|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.157731082679119,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.20769587621197,10.9386948233332,0.523523743973798,28.2351114254887,10.2456822743767,3.88408282424923,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.161766849947409,0,0,0,0,0,0,0.239630249011841,0,0.127070227073065,0,0,0,0,0,0,0,0,0.248813941220186,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.13665399758237,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.224862112384854,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.163863314715738,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.295301892880773,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.161464426695906,0,0,0.164140899745061,0,0,0,0.206386867963223,0.185194527369712,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.194451188344048,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.192909220463705,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr5:137453946..137453948,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=6 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr5:137453946..137453948,+ | |||
|description=CAGE_peak_at_chr5:137453946..137453948,+ | |||
|id=chr5:137453946..137453948,+ | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2=CL:0000355,1.75e-07,9 | |||
|ontology_enrichment_disease=DOID:0060100!2.69e-14!3;DOID:4045!2.69e-14!3;DOID:0050686!2.26e-07!6 | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,1.99e-20,3;DOID:4045,1.99e-20,3;DOID:0050686,9.54e-11,6 | |||
|ontology_enrichment_uberon= | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,1.75e-07,9;UBERON:0002036,1.75e-07,9;UBERON:0002385,1.75e-07,9;UBERON:0000486,1.75e-07,9;UBERON:0007503,1.75e-07,9;UBERON:0001015,1.75e-07,9;UBERON:0002329,1.75e-07,9;UBERON:0003082,1.75e-07,9;UBERON:0003059,1.75e-07,9;UBERON:0007282,1.75e-07,9;UBERON:0004290,1.75e-07,9;UBERON:0009618,1.75e-07,9;UBERON:0000383,7.98e-07,10 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.157731082679119,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.20769587621197,10.9386948233332,0.523523743973798,28.2351114254887,10.2456822743767,3.88408282424923,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.161766849947409,0,0,0,0,0,0,0.239630249011841,0,0.127070227073065,0,0,0,0,0,0,0,0,0.248813941220186,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.13665399758237,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.224862112384854,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.163863314715738,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.295301892880773,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.161464426695906,0,0,0.164140899745061,0,0,0,0.206386867963223,0.185194527369712,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.194451188344048,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.192909220463705,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr5:137453946..137453948,+ | |||
}} |
Latest revision as of 20:46, 3 August 2015
Short description: | p@chr5:137453946..137453948, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr5:137453946..137453948, + |
Coexpression cluster: | MCL_coexpression_mm9:6 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
multi-potent skeletal muscle stem cell | 1.75e-07 | 9 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 1.75e-07 | 9 |
striated muscle tissue | 1.75e-07 | 9 |
muscle tissue | 1.75e-07 | 9 |
multilaminar epithelium | 1.75e-07 | 9 |
epithelial vesicle | 1.75e-07 | 9 |
musculature | 1.75e-07 | 9 |
somite | 1.75e-07 | 9 |
myotome | 1.75e-07 | 9 |
presomitic mesoderm | 1.75e-07 | 9 |
presumptive segmental plate | 1.75e-07 | 9 |
dermomyotome | 1.75e-07 | 9 |
trunk paraxial mesoderm | 1.75e-07 | 9 |
musculature of body | 7.98e-07 | 10 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 1.99e-20 | 3 |
muscle cancer | 1.99e-20 | 3 |
organ system cancer | 9.54e-11 | 6 |